Biomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature
Jennifer C. Munoz Pareja,Xue Li,Nithya Gandham,Kevin K. Wang,The Pediatric TBI Workgroup,Lauren Lautenslager,Maria Camila Pareja,Prashanth Shanmugham,Shannon Faulkinberry,Suman Ghosh,Maria Kerrigan,Madhuri R. Kashyap
DOI: https://doi.org/10.1016/j.pediatrneurol.2022.03.002
IF: 4.21
2022-05-01
Pediatric Neurology
Abstract:ObjectiveDespite decades of research, outcomes in pediatric traumatic brain injury (pTBI) remain highly variable. Brain biofluid-specific biomarkers from pTBI patients may allow us to diagnose and prognosticate earlier and with a greater degree of accuracy than conventional methods. This manuscript reviews the evidence surrounding current brain-specific biomarkers in pTBI and assess the temporal relationship between the natural history of the traumatic brain injury (TBI) and measured biomarker levels.MethodsA literature search was conducted in the Ovid, PubMed, MEDLINE, and Cochrane databases seeking relevant publications. The study selection and screening process were documented in a PRISMA flow diagram. Extraction forms included developmental stages of patients, type and biofluid source of biomarkers, brain injury type, and other relevant data.ResultsThe search strategy identified 443 articles, of which 150 examining the biomarkers of our interest, were included. The references retrieved were examined thoroughly and discussed at length with a pediatric neurocritical care intensivist specializing in pTBI and a Ph.D. scientist with a high degree of involvement in TBI biomarker research, authoring a vast amount of literature in this field.ConclusionTBI biomarkers might serve as valuable tools in the diagnosis and prognosis of pTBI. However, while each biomarker has its advantages, they are not without limitations, and therefore, further research is critical in pTBI biomarkers.
pediatrics,clinical neurology